Compounds > amifampridine
Page last updated: 2024-11-08

amifampridine and Syndrome

amifampridine has been researched along with Syndrome in 2 studies

Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.

Syndrome: A characteristic symptom complex.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lundh, H1
Nilsson, O1
Rosén, I1
Sieb, JP1

Reviews

1 review available for amifampridine and Syndrome

ArticleYear
[Diagnosis and therapy of congenital myasthenia syndrome].
    Deutsche medizinische Wochenschrift (1946), 1999, Jan-08, Volume: 124, Issue:1-2

    Topics: 4-Aminopyridine; Adult; Amifampridine; Central Nervous System Stimulants; Child; Cholinesterase Inhi

1999

Other Studies

1 other study available for amifampridine and Syndrome

ArticleYear
Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine.
    Neurology, 1984, Volume: 34, Issue:10

    Topics: 4-Aminopyridine; Aged; Amifampridine; Aminopyridines; Autoimmune Diseases; Female; Humans; Middle Ag

1984